Melola Discovery

← Melola Discovery

Akses terbuka Jurnal

In Silico Evaluation of Drug-Likeness, ADMET Profile, and Toxicity of Antimalarial Compounds from the Bark of Alstonia scholaris

Jurnal Biodjati · Vol. 11 No. 1 (2026) · hlm. 78–89

DOI
10.15575/biodjati.v11i1.53359
ISSN
2541-4208, 2548-1606
Terbit
2026-05-31
Penerbit
UIN Sunan Gunung Djati Bandung
Bahasa
eng
Lisensi
creativecommons.org/licenses/by-nc-nd/4.0

Abstrak

Malaria remains a major global health problem, particularly in tropical countries, highlighting the need for new antimalarial agents with favorable pharmacokinetic and safety profiles. This study aimed to evaluate the drug-likeness, ADMET properties, and toxicity of six bioactive compounds derived from Alstonia scholaris bark using an in silico approach. Computational analyses were performed using SwissADME, pkCSM, AdmetSAR, and ProTox-3.0 to assess absorption, distribution, metabolism, excretion, and toxicity parameters, as well as Lipinski’s Rule of Five. The results showed that four compounds met all Lipinski criteria, while two exhibited logP values greater than 5, suggesting potential limitations in lipophilicity. Predicted VDss values suggested moderate and variable systemic distribution, and none of the compounds were predicted to interact with CYP2D6. Toxicity analysis indicated generally low toxicity, with α-Amyrin classified as non-toxic (LD₅₀ = 70,000 mg/kg; toxicity class VI). Among the compounds, Spirost-8-en-11-one demonstrated the most favorable pharmacokinetic profile, with high gastrointestinal absorption and the highest total clearance. In conclusion, the evaluated compounds exhibit promising pharmacokinetic and safety profiles as potential antimalarial candidates. These findings provide preliminary computational evidence supporting further in vitro and in vivo validation to confirm their efficacy and safety.

Kata kunci

Jaringan kolaborasi para penulis

29 penulis · 137 tautan kepenulisan bersama · 34 lintas organisasi

Arahkan kursor atau ketuk sebuah nama untuk menyorot rekan penulisnya. Klik dua kali untuk membuka halaman penulis.

  • Universitas Airlangga
  • Universitas Nusantara PGRI Kediri
  • Yogyakarta State University
  • Sultan Idris Education University
  • University of Singaperbangsa Karawang
  • Universitas Muhammadiyah Prof Dr Hamka
  • State University of Malang
  • Organisasi lain
  • Afiliasi tidak diketahui
  • Organisasi berbeda
  • Organisasi sama
  • Afiliasi tidak diketahui
  • Garis lebih tebal = lebih banyak artikel bersama · lingkaran lebih besar = lebih banyak artikel
Tampilkan sebagai tabel
Rekan penulisOrganisasiArtikel bersama
Sri Pantja MadyawatiUniversitas Airlangga2
Pudji SriantoUniversitas Airlangga2
Erma SafitriUniversitas Airlangga2
Heni PuspitasariUniversitas Airlangga2
Epy Muhammad LuqmanUniversitas Airlangga2
Tri Wahyu SuprayogiUniversitas Airlangga2
Tita Damayanti LestariUniversitas Airlangga2
Dicky Mohammad DikmanUniversitas Airlangga2
Jekmal MalauUniversity of Singaperbangsa Karawang1
Muhareva RaekiansyahAfiliasi tidak diketahui1
Edwin YulianAfiliasi tidak diketahui1
Imam HardimanUniversitas Muhammadiyah Prof Dr Hamka1
Rizqa Devi AnazifaYogyakarta State University1
Ahmad Kamal SudrajatState University of Malang1
Atik KurniawatiYogyakarta State University1
Supriyadi SupriyadiSerang Raya University1
Muhammad 'Ahdi KurniawanUniversitas Airlangga1
Aulanni’amUniversity of Brawijaya1
SupriyadiAfiliasi tidak diketahui1
Gabriel Sampe PasangAfiliasi tidak diketahui1

Afiliasi berasal dari OpenAlex; metadata OAI-PMH jurnal tidak memuatnya. Penulis tanpa ID OpenAlex dicocokkan berdasarkan nama, sehingga dua orang bisa tergabung atau satu orang bisa terpisah.

Sumber metadata: OAI-PMH (metadata jurnal) https://journal.uinsgd.ac.id/index.php/biodjati/oai, pertama di-harvest 7 Nov 2026, terakhir terlihat 8 Nov 2026.
Metadata asli (oai_dc)
<oai_dc:dc xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/  http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en-US">In Silico Evaluation of Drug-Likeness, ADMET Profile, and Toxicity of Antimalarial Compounds from the Bark of Alstonia scholaris</dc:title>
	<dc:creator>Zakki Aqimul Haq, Mohammad</dc:creator>
	<dc:creator>Fahriza, M. Raffi</dc:creator>
	<dc:creator>Taufan Insani, Gilang</dc:creator>
	<dc:creator>Putra Rahmatullah, M. Fauzan</dc:creator>
	<dc:creator>Waluyo, Seagames</dc:creator>
	<dc:creator>Tias Pratama, Anggi</dc:creator>
	<dc:creator>Bahiyah Abd Wahid, Nurul</dc:creator>
	<dc:creator>Rahmatika Primandiri, Poppy</dc:creator>
	<dc:creator>Santoso, Agus Muji</dc:creator>
	<dc:subject xml:lang="en-US">alstonia scholaris</dc:subject>
	<dc:subject xml:lang="en-US">in silico</dc:subject>
	<dc:subject xml:lang="en-US">malaria</dc:subject>
	<dc:subject xml:lang="en-US">toxicity</dc:subject>
	<dc:description xml:lang="en-US">Malaria remains a major global health problem, particularly in tropical countries, highlighting the need for new antimalarial agents with favorable pharmacokinetic and safety profiles. This study aimed to evaluate the drug-likeness, ADMET properties, and toxicity of six bioactive compounds derived from Alstonia scholaris bark using an in silico approach.  Computational analyses were performed using SwissADME, pkCSM, AdmetSAR, and ProTox-3.0 to assess absorption, distribution, metabolism, excretion, and toxicity parameters, as well as Lipinski’s Rule of Five. The results showed that four compounds met all Lipinski criteria, while two exhibited logP values greater than 5, suggesting potential limitations in lipophilicity. Predicted VDss values suggested moderate and variable systemic distribution, and none of the compounds were predicted to interact with CYP2D6. Toxicity analysis indicated generally low toxicity, with α-Amyrin classified as non-toxic (LD₅₀ = 70,000 mg/kg; toxicity class VI). Among the compounds, Spirost-8-en-11-one demonstrated the most favorable pharmacokinetic profile, with high gastrointestinal absorption and the highest total clearance. In conclusion, the evaluated compounds exhibit promising pharmacokinetic and safety profiles as potential antimalarial candidates. These findings provide preliminary computational evidence supporting further in vitro and in vivo validation to confirm their efficacy and safety.</dc:description>
	<dc:publisher xml:lang="en-US">UIN Sunan Gunung Djati Bandung</dc:publisher>
	<dc:date>2026-05-31</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:type xml:lang="en-US">Peer-reviewed Article</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://journal.uinsgd.ac.id/index.php/biodjati/article/view/53359</dc:identifier>
	<dc:identifier>10.15575/biodjati.v11i1.53359</dc:identifier>
	<dc:source xml:lang="en-US">Jurnal Biodjati; Vol. 11 No. 1 (2026): May; 78-89</dc:source>
	<dc:source xml:lang="id-ID">Jurnal Biodjati; Vol 11 No 1 (2026): May; 78-89</dc:source>
	<dc:source>2541-4208</dc:source>
	<dc:source>2548-1606</dc:source>
	<dc:language>eng</dc:language>
	<dc:relation>https://journal.uinsgd.ac.id/index.php/biodjati/article/view/53359/16500</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2026 Jurnal Biodjati</dc:rights>
	<dc:rights xml:lang="en-US">https://creativecommons.org/licenses/by-nc-nd/4.0</dc:rights>
</oai_dc:dc>